Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients
Status:
Unknown status
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
In the current research the investigators would like to examine the effect of a well
acquainted drug, Ketamine, which is used by anesthesiologists to induce sleep in operations.
Usually the ketamine is given into the vein and not orally. The investigators want to give it
orally to cancer patients that sufffer from severe pain to find out whether it can prove
their quality of life, lower their pain and reduce the amount of opioids they receive.